Effects of esomeprazole +/- mosapride on oesophageal peristaltic function in patients with gastro-oesophageal disease

Trial Profile

Effects of esomeprazole +/- mosapride on oesophageal peristaltic function in patients with gastro-oesophageal disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2013

At a glance

  • Drugs Esomeprazole; Mosapride
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top